Measurement of overall coagulabity during coumar in treatment with reference to the Quick test.

[1]  J. Roskam,et al.  Etude clinique ”in vivo” de la Résistance du Clou hémostatique chez l’Homme , 1959, Thrombosis and Haemostasis.

[2]  C. Borchgrevink,et al.  The secondary bleeding time; a new method for the differentiation of hemorrhagic diseases. , 2009, Acta medica Scandinavica.

[3]  R. Macmillan,et al.  A MODIFICATION OF THE THROMBOPLASTIN GENERATION TEST , 1958, The American journal of the medical sciences.

[4]  I. Nilsson,et al.  Von Willebrand's disease and its correction with human plasma fraction 1-0. , 2009, Acta medica Scandinavica.

[5]  M. Verstraete,et al.  Use of Different Tissue Thromboplastins in the Control of Anticoagulant Therapy , 1957, Circulation.

[6]  J. Jurgens.  [Sodium chloride tolerance test for discovery of latent coagulation disorders: heparin tolerance test without heparin]. , 1956, Blut.

[7]  W. Connell,et al.  Effect of bishydroxycoumarin (dicumarol) on clotting time of whole blood. , 1956, Journal of the American Medical Association.

[8]  Rosenthal Rl.  Over-all coagulability in patients receiving dicumarol therapy with emphasis on acute myocardial infarction. , 1956 .

[9]  D. Bergsagel,et al.  Intermediate Stages in the Formation of Blood Thromboplastin , 1956, British journal of haematology.

[10]  Douglas As.  The coagulation defect caused by tromexan therapy. , 1955 .

[11]  A. S. Douglas,et al.  The Thromboplastin Generation Test , 1953, Journal of clinical pathology.

[12]  R. Rosenthal,et al.  Acceleration of Blood Coagulation in Acute Myocardial Infarction as Demonstrated by the Heparin Clotting Time; Effect of Dicumarol Therapy , 1952, Circulation.

[13]  P. Owren,et al.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. , 1951, Scandinavian journal of clinical and laboratory investigation.

[14]  L. Jaques.  A fundamental consideration of anticoagulant therapy. , 1950, The New England journal of medicine.

[15]  N. W. Barker,et al.  THE COAGULATION TIME OF BLOOD IN SILICONS TUBES , 1949, The American journal of the medical sciences.

[16]  N. W. Barker,et al.  THE COAGULATION TIME OF BLOOD IN SILICONE TUBES IN PATIENTS RECEIVING DICUMAROL , 1949, The American journal of the medical sciences.

[17]  P. Owren.  A quantitative one-stage method for the assay of prothrombin. , 1949, Scandinavian journal of clinical and laboratory investigation.

[18]  W. Harrington,et al.  Prolongation of the coagulation of whole blood by dicumarol in man. , 1948, The American journal of medicine.

[19]  A. H. Kadish.  Coagulation time of the blood in lusteroid tubes; a study of patients receiving dicumarol. , 1947, American heart journal.

[20]  C. S. Davidson,et al.  A CRITICAL STUDY OF THE ACTION OF 3—3'—METHLYLENEBIS (4-HYDROXYCOUMARIN) (DICOUMARIN) , 1943 .

[21]  P. White,et al.  A CLINICAL STUDY OF THE COAGULATION TIME OF BLOOD , 1913 .